Even at $500K, Gene Therapy Could Be a Bargain for Some Diseases – MIT Technology Review
MIT Technology Review |
Even at $500K, Gene Therapy Could Be a Bargain for Some Diseases
MIT Technology Review The U.S. Food and Drug Administration recently approved what it called the “first gene therapy” in the country. The therapy, called Kymriah and made by Novartis, uses a patient's own cells—which are genetically modified outside the body—to treat a … Novel Gene Therapy and Antisense Drugs to Offer Effective Cancer Cure |
